ProtoKinetix, Incorporated

PKTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $0 $0 $0 $0 $0
Cost of Revenue — — — — —
Gross Profit — — — — —
Gross Margin — — — — —
Operating Expenses
Research & Development $13.8K $74.5K $0 $117.4K $161.5K
SG&A Expense $141.5K $95.8K $119.4K $201.0K $213.0K
Operating Income — $-422.2K $-197.1K $-916.9K $-1.4M
Operating Margin — — — — —
Interest Expense $34.4K $26.4K $24.0K $12.0K $24.0K
Pretax Income — $-448.6K $-197.1K $-1.2M $-1.4M
Income Tax Expense — — — — —
Net Income $-168.5K $-448.6K $-197.1K $-1.2M $-1.4M
Net Margin — — — — —
EPS (Basic) $0.00 $0.00 $0.00 $-0.01 $-0.02
EPS (Diluted) $0.00 $0.00 $0.00 $-0.01 $-0.02
Shares Outstanding (Basic) — — — — —
Shares Outstanding (Diluted) 172.4M 137.1M 129.2M 93.6M 75.5M
Dividends Per Share — — — — —